F16.10
Hallucinogen abuse, uncomplicated
Clinical Classification Guidelines
Inclusion Terms
- Other hallucinogen use disorder, mild
- Phencyclidine use disorder, mild
Medical Intelligence & Overview
Hallucinogen abuse, classified under ICD-10 code F16.10, refers to the illegal or harmful use of substances that cause altered perceptions, thoughts, and feelings. This condition involves the misuse of hallucinogenic drugs, including substances like LSD, psilocybin (magic mushrooms), and phencyclidine (PCP), among others. When the abuse is considered uncomplicated, it means there are no significant health complications or co-occurring medical issues at the time of assessment. The condition is categorized as mild, indicating relatively less severe effects or dependence. Understanding this diagnosis helps in recognizing the nature of hallucinogen misuse and the importance of addressing substance use behaviors when they arise.
Causes & Symptoms
Clinical Causes: Experimentation with illegal substances for recreational or spiritual reasons Peer influence and social environments that promote drug use Mental health conditions such as anxiety or depression leading to substance use as coping Curiosity or desire for altered states of consciousness Lack of awareness about the potential risks and legal consequences of drug misuse
Key Symptoms: Altered perceptions of sights, sounds, and feelings Visual hallucinations or distortions Altered sense of time and space Mood swings or unusual emotional responses Confusion or disorganized thinking Impaired judgment and coordination Dizziness or nausea in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on clinical evaluation, including patient history and behavioral assessment. Healthcare professionals consider reports of drug use, frequency, and effects experienced. No standard laboratory test can definitively diagnose hallucinogen abuse, but urine or blood tests may detect recent use. The diagnosis of uncomplicated, mild hallucinogen use disorder suggests that the individual's usage patterns are not currently associated with severe health issues or dependencies. Accurate assessment ensures appropriate intervention and support.
Treatment Protocols: Counseling or psychotherapy to explore reasons for drug use and develop healthier habits Education about the risks linked to hallucinogen misuse Support groups for individuals struggling with substance use behaviors Monitoring and follow-up to prevent escalation or complications Addressing underlying mental health issues that may contribute to drug misuse
Clinical Advice & FAQs
Billing Guidance
Is F16.10 a billable ICD-10 code?
Yes, F16.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.10?
Clinical documentation must specify the nature of Hallucinogen abuse, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference